D-Index & Metrics Best Publications
Research.com 2022 Best Female Scientist Award Badge

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 145 Citations 73,526 549 World Ranking 529 National Ranking 330
Best female scientists D-index 145 Citations 73,772 613 World Ranking 123 National Ranking 79

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Female Scientist Award

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Cancer
  • Surgery

Her primary scientific interests are in Internal medicine, Transplantation, Surgery, Hematopoietic stem cell transplantation and Bone marrow. Her Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Oncology and Histocompatibility. Her work deals with themes such as Leukemia, Immunology and Human leukocyte antigen, which intersect with Transplantation.

The various areas that Mary M. Horowitz examines in her Leukemia study include Myeloid and Chronic phase chronic myelogenous leukemia. Her Hematopoietic stem cell transplantation research is multidisciplinary, incorporating perspectives in Case-control study, Total body irradiation, Hematopoietic stem cell, Transplantation Conditioning and Pediatrics. Her Bone marrow research is multidisciplinary, incorporating elements of Disease, Acute lymphocytic leukemia and Risk factor.

Her most cited work include:

  • Graft-versus-leukemia reactions after bone marrow transplantation (2489 citations)
  • Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet (1095 citations)
  • Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet (1091 citations)

What are the main themes of her work throughout her whole career to date?

Mary M. Horowitz spends much of her time researching Internal medicine, Transplantation, Surgery, Hematopoietic stem cell transplantation and Oncology. In most of her Internal medicine studies, her work intersects topics such as Gastroenterology. Her Transplantation research includes themes of Hematopoietic cell, Human leukocyte antigen, Histocompatibility and Immunology.

As part of her studies on Surgery, Mary M. Horowitz often connects relevant areas like Transplantation Conditioning. Her Hematopoietic stem cell transplantation study incorporates themes from Retrospective cohort study, Myeloid leukemia, Myelodysplastic syndromes, Pediatrics and Cohort. Her Oncology research includes elements of Cancer and Bone marrow transplantation.

She most often published in these fields:

  • Internal medicine (72.44%)
  • Transplantation (74.33%)
  • Surgery (38.74%)

What were the highlights of her more recent work (between 2017-2021)?

  • Transplantation (74.33%)
  • Internal medicine (72.44%)
  • Clinical trial (14.17%)

In recent papers she was focusing on the following fields of study:

Mary M. Horowitz mainly focuses on Transplantation, Internal medicine, Clinical trial, Oncology and Hematopoietic cell. Her study in Transplantation focuses on Graft-versus-host disease in particular. Her work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Human leukocyte antigen.

Her work is dedicated to discovering how Oncology, Multiple myeloma are connected with Surgical oncology and Tolerability and other disciplines. The study incorporates disciplines such as Quality of life, Immunology and Marrow transplantation in addition to Hematopoietic cell. Her Hematopoietic stem cell transplantation research incorporates themes from Young adult, Survival analysis and Incidence.

Between 2017 and 2021, her most popular works were:

  • Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial (95 citations)
  • Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203) (73 citations)
  • Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies. (52 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

Mary M. Horowitz mainly investigates Transplantation, Internal medicine, Hematopoietic stem cell transplantation, Oncology and Gastroenterology. A large part of her Transplantation studies is devoted to Graft-versus-host disease. Her study on Hematopoietic stem cell transplantation also encompasses disciplines like

  • Survival analysis which is related to area like Donor selection,
  • Incidence which is related to area like Complication.

Her studies in Oncology integrate themes in fields like Human leukocyte antigen, Disease and Immunotherapy. Clofarabine is closely connected to Total body irradiation in her research, which is encompassed under the umbrella topic of Gastroenterology. Mary M. Horowitz has included themes like Surgery and Propensity score matching in her Bone marrow study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Graft-versus-leukemia reactions after bone marrow transplantation

MM Horowitz;RP Gale;PM Sondel;JM Goldman.
Blood (1990)

3186 Citations

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

Michele Baccarani;Giuseppe Saglio;John Goldman;Andreas Hochhaus.
Blood (2006)

1700 Citations

Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

Michele Baccarani;Jorge Cortes;Fabrizio Pane;Dietger Niederwieser.
Journal of Clinical Oncology (2009)

1667 Citations

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Stephanie J. Lee;John Klein;Michael Haagenson;Lee Ann Baxter-Lowe.
Blood (2007)

1296 Citations

Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia

Mary J. Laughlin;Mary Eapen;Pablo Rubinstein;John E. Wagner.
The New England Journal of Medicine (2004)

1281 Citations

Defining the intensity of conditioning regimens: working definitions.

Andrea Bacigalupo;Karen Ballen;Doug Rizzo;Sergio Giralt.
Biology of Blood and Marrow Transplantation (2009)

1221 Citations

Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.

Vanderson Rocha;John E. Wagner;Kathleen A. Sobocinski;John P. Klein.
The New England Journal of Medicine (2000)

1209 Citations

Lenalidomide after stem-cell transplantation for multiple myeloma

Philip L. McCarthy;Kouros Owzar;Craig C. Hofmeister;David D. Hurd.
The New England Journal of Medicine (2012)

1132 Citations

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

John M. Goldman;Robert Peter Gale;Mary M. Horowitz;James C. Biggs.
Annals of Internal Medicine (1988)

1025 Citations

Solid Cancers after Bone Marrow Transplantation

Rochelle E. Curtis;Philip A. Rowlings;H. Joachim Deeg;Donna A. Shriner.
The New England Journal of Medicine (1997)

982 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mary M. Horowitz

Arnon Nagler

Arnon Nagler

Sheba Medical Center

Publications: 378

Sergio Giralt

Sergio Giralt

Memorial Sloan Kettering Cancer Center

Publications: 364

Mohamad Mohty

Mohamad Mohty

Université Paris Cité

Publications: 341

Richard E. Champlin

Richard E. Champlin

The University of Texas MD Anderson Cancer Center

Publications: 304

Daniel J. Weisdorf

Daniel J. Weisdorf

University of Minnesota

Publications: 294

Bipin N. Savani

Bipin N. Savani

Vanderbilt University Medical Center

Publications: 284

Gérard Socié

Gérard Socié

Université Paris Cité

Publications: 281

Hillard M. Lazarus

Hillard M. Lazarus

Case Western Reserve University

Publications: 273

Myriam Labopin

Myriam Labopin

Université Paris Cité

Publications: 264

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 251

Rainer Storb

Rainer Storb

Fred Hutchinson Cancer Research Center

Publications: 243

Xiao-Jun Huang

Xiao-Jun Huang

Peking University

Publications: 227

Stephanie J. Lee

Stephanie J. Lee

Fred Hutchinson Cancer Research Center

Publications: 224

Paul J. Martin

Paul J. Martin

Fred Hutchinson Cancer Research Center

Publications: 211

Joseph H. Antin

Joseph H. Antin

Harvard University

Publications: 211

Jorge E. Cortes

Jorge E. Cortes

Augusta University

Publications: 206

Trending Scientists

Naim Kapucu

Naim Kapucu

University of Central Florida

Paula Jarzabkowski

Paula Jarzabkowski

City, University of London

Martin Karafiat

Martin Karafiat

Brno University of Technology

Patrick Lincoln

Patrick Lincoln

SRI International

Tim D. Fletcher

Tim D. Fletcher

University of Melbourne

Maria Petrou

Maria Petrou

Imperial College London

Kenneth Kam-Wing Lo

Kenneth Kam-Wing Lo

City University of Hong Kong

Hiroyuki Tanaka

Hiroyuki Tanaka

Kyushu University

Rong Sun

Rong Sun

Chinese Academy of Sciences

Zhimin Lu

Zhimin Lu

Zhejiang University

Hiroshi Sano

Hiroshi Sano

Nara Institute of Science and Technology

Martin Ziegler

Martin Ziegler

Utrecht University

Ekrem Dere

Ekrem Dere

Max Planck Society

David J. Burn

David J. Burn

Newcastle University

Rob S. Beanlands

Rob S. Beanlands

University of Ottawa

Something went wrong. Please try again later.